Veeva Systems (NYSE:VEEV) Price Target Raised to $260.00

Veeva Systems (NYSE:VEEV) had its target price lifted by Canaccord Genuity Group from $220.00 to $260.00 in a research note released on Thursday morning,Benzinga reports. The firm currently has a hold rating on the technology company’s stock.

Other research analysts have also issued reports about the stock. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a research report on Monday, August 3rd. Wells Fargo & Company increased their price objective on Veeva Systems from $317.00 to $320.00 and gave the stock an “overweight” rating in a research report on Thursday, June 4th. Jefferies Financial Group reissued a “buy” rating and set a $295.00 price objective on shares of Veeva Systems in a research note on Thursday. BMO Capital Markets reduced their target price on Veeva Systems from $220.00 to $175.00 and set a “market perform” rating for the company in a research report on Thursday, June 4th. Finally, Royal Bank Of Canada upped their target price on Veeva Systems from $275.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday. Nineteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Veeva Systems presently has a consensus rating of “Moderate Buy” and an average price target of $284.46.

Veeva Systems Trading Down 1.7%

VEEV stock opened at $277.27 on Thursday. The firm has a 50 day moving average of $208.48 and a 200-day moving average of $184.39. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50. The firm has a market capitalization of $45.04 billion, a P/E ratio of 45.60, a price-to-earnings-growth ratio of 1.19 and a beta of 0.92.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.23 by $0.12. The company had revenue of $927.96 million during the quarter, compared to analysts’ expectations of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. Veeva Systems’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Sell-side analysts predict that Veeva Systems will post 6.65 EPS for the current year.

Insiders Place Their Bets

In related news, insider Thomas D. Schwenger sold 36,000 shares of the firm’s stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. This trade represents a 64.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by insiders.

Institutional Investors Weigh In On Veeva Systems

Hedge funds have recently made changes to their positions in the business. SHP Wealth Management purchased a new position in Veeva Systems in the 4th quarter worth $26,000. Activest Wealth Management boosted its position in Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 127 shares during the period. MV Capital Management Inc. purchased a new stake in Veeva Systems during the fourth quarter valued at about $30,000. Reflection Asset Management bought a new position in shares of Veeva Systems during the fourth quarter valued at about $32,000. Finally, BOK Financial Private Wealth Inc. bought a new position in shares of Veeva Systems during the fourth quarter valued at about $33,000. 88.20% of the stock is currently owned by institutional investors.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Beat-and-raise quarter: Veeva reported fiscal Q2 revenue of approximately $928 million, up 17.6% year over year and above expectations. Non-GAAP EPS of $2.35 also exceeded consensus, while next-quarter revenue guidance of about $933.5 million was roughly 1.5% ahead of estimates. VEEV Q2 Deep Dive: AI Expansion, CRM Wins, and Accelerating R&D Cloud Adoption
• Positive Sentiment: AI and CRM momentum: Management highlighted demand for its Falcon AI platform, record Vault CRM execution and increasing adoption of its Commercial Cloud products. The company expects its first Falcon customers to go live this year, supporting the growth outlook. VEEV Q2 Earnings Call Centers on Falcon and CRM Momentum
• Positive Sentiment: Shareholder returns and financial strength: Veeva’s $2 billion buyback—of which about $1.4 billion reportedly remains—may offset stock-based compensation and support EPS growth. Approximately $1.8 billion in cash, $5.4 billion in short-term investments and minimal debt provide balance-sheet flexibility.
• Positive Sentiment: Higher bullish targets: Barclays raised its target to $315, RBC to $325, Guggenheim to $310, Truist to $305 and Robert W. Baird to $300, with buy, outperform or overweight ratings. Analyst price-target updates
• Neutral Sentiment: Valuation is demanding: VEEV trades near $277, with a reported P/E ratio of 45.6, leaving less room for execution mistakes after the recent rally.
• Negative Sentiment: Analyst caution and consolidation: Citi maintained a neutral rating with a $273 target, while BMO, Canaccord and Morgan Stanley targets were below the current price. The latest weakness may therefore represent consolidation as investors digest strong results and reassess the stock’s premium valuation.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.